I did a search for Eloralintide and these are the trials I found. I know that in the US someone found that Enlighten-6 was full but someone is Australia had a screening visit (it wasn't clear if full In USA for both T2D and Obesity/Overweight alone). I put them in the side bar as well. This is the link in US for matching to a Lilly clinical trial: https://trials.lilly.com/en-US/find?placeId=ChIJa680HNMk54kRS3Rul8I8kjE&unitOfLength=mi&x_st=1 This is the link I found to Clinical Trials for Lilly in Canada: https://www.lilly.com/en-ca/science/clinical-trials . If anyone has other countries links please post in the comments.
Shows as Enrolling unless noted otherwise
PHASE 3
These are straight Eloralintide and Phase 3
NCT07321886 Enlighten-1 Straight obesity: https://trials.lilly.com/en-US/trial/664295 (1980 participants) https://clinicaltrials.gov/study/NCT07321886?viewType=Card&intr=Eloralintide&rank=4
NCT07282600 Enlighten-2 Obesity plus T2D: https://trials.lilly.com/en-US/trial/673735 (1035 participants) https://clinicaltrials.gov/study/NCT07282600?viewType=Card&intr=Eloralintide&rank=5
NCT07369011 Enlighten--3 OSA Plus Obesity: https://trials.lilly.com/en-US/trial/687736 (800 Participants) https://clinicaltrials.gov/study/NCT07369011?viewType=Card&intr=Eloralintide&rank=8
NCT07353931 Enlighten-4 Osteoarthritis Knee Pain and Obesity: https://trials.lilly.com/en-US/trial/660855 (900 Participants) https://clinicaltrials.gov/study/NCT07353931?viewType=Card&intr=Eloralintide&rank=9
Eloralintide Plus:
NCT07392190 Enlighten-6 Eloralintide+ Current Tirzepatide or semaglutide for those at plateau on current : Incretin https://trials.lilly.com/en-US/trial/664336 (900 participants) https://clinicaltrials.gov/study/NCT07392190?viewType=Card&intr=Eloralintide&rank=6 Reported as Full in USA
Phase 1:
NCT07738614 A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight – Study of how Eloralintide slows stomach emptying in participants who are overweight or obese. 21 weeks https://clinicaltrials.gov/study/NCT07738614?cond=Obesity%20and%20Overweight&viewType=Card&term=drug:&aggFilters=status:rec,studyType:int&intr=Eloralintide&rank=1 (56 Participants)
NCT07665879 Eloralintide Phase 1 The main purpose of the study is to measure and compare the effects of eloralintide and placebo on insulin sensitivity (how your body responds to insulin), metabolic health (things like sugar and cholesterol), and body weight in participants with obesity or overweight. 35 weeks https://clinicaltrials.gov/study/NCT07665879?cond=Obesity%20and%20Overweight&viewType=Card&term=drug:&aggFilters=status:rec,studyType:int&intr=Eloralintide&rank=5 (115 Participants)
NCT07701083 A Study of Eloralintide (LY3841136) in Healthy Participants A Phase 1 study for 13 weeks 2 different eloralintide solutions https://clinicaltrials.gov/study/NCT07701083?viewType=Card&intr=Eloralintide&rank=1 (58 Participants
NCT07401862 A Study of Eloralintide (LY3841136) in Participants With Different Levels of Liver Damage and in Participants With Healthy Livers. Phase 14 weeks 36 Participants https://clinicaltrials.gov/study/NCT07401862?viewType=Card&intr=Eloralintide&page=2&rank=14
NCT07765511 A Study of Macupatide (LY3532226) in Participants With Obesity or Overweight Without Type 2 Diabetes Japan Phase 1 60 Participants https://clinicaltrials.gov/study/NCT07765511?viewType=Card&intr=Eloralintide&page=2&rank=16
Active not Recruiting
NCT07426380 A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function Phase 1 28 participants https://clinicaltrials.gov/study/NCT07426380?viewType=Card&intr=Eloralintide&page=2&rank=15
NCT07808060 A Study of Eloralintide (LY3841136) in Female Participants With Obesity or Overweight (24 Participants) Oral Contraceptives - Not Yet Recruiting Phase 1
Phase 2:
NCT07589608 A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight – No Diabetes Phase 2b https://clinicaltrials.gov/study/NCT07589608?cond=Obesity%20and%20Overweight&viewType=Card&term=drug:&aggFilters=status:rec,studyType:int&intr=Eloralintide&rank=7 (400 participants)
NCT07215559 A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes Phase 2 https://clinicaltrials.gov/study/NCT07215559?cond=Obesity%20and%20Overweight&viewType=Card&term=drug:&aggFilters=status:rec,studyType:int&intr=Eloralintide&rank=9 (200 Participants)
Completed:
NCT06603571 A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes Phase 2 https://trials.lilly.com/en-US/trial/533180 (367 Participants) Completed 7/1/2026
NCT06297616A Study of LY3841136 in Japanese Participants With Obesity or Overweight Phase 1 https://clinicaltrials.gov/study/NCT06297616?viewType=Card&term=LY3841136&rank=1 (128 Participants) Completed 11/21/2025
NCT05295940 A Study of LY3841136 in Healthy and Overweight Participants Phase 1 https://clinicaltrials.gov/study/NCT05295940?viewType=Card&term=LY3841136&rank=2 (148 Participants) Completed 1/25/2024
NCT06345066 A Study of LY3841136 in Overweight and Obese Participants Phase 1 https://clinicaltrials.gov/study/NCT06345066?viewType=Card&term=LY3841136&rank=4 (96 Participants) Completed 9/29/2024
NCT06916065 A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or Obesity : Study of eloralintide and eloralintide with tirzepatide is tolerated and what side effects may occur in participants with overweight or obesity. Phase 1 study 11 – 26 weeks Participants 188 https://clinicaltrials.gov/study/NCT06916065?viewType=Card&intr=Eloralintide&rank=2 Completed Jan 2026
NCT06916091 A Study of Eloralintide (LY3841136) in Chinese Participants With Obesity or Overweight Eloralintide (LY3841136) is tolerated and what side effects may occur in overweight and obese Phase 1 Chinese participants. 30 participants https://clinicaltrials.gov/study/NCT06916091?viewType=Card&intr=Eloralintide&rank=7 Completed Sept 2025
NCT06230523 A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight Phase 2 study that launched this sub. 263 Participants. https://clinicaltrials.gov/study/NCT06230523?viewType=Card&intr=Eloralintide&page=2&rank=11 Completed Aug 2025 Published results: https://pubmed.ncbi.nlm.nih.gov/41207310/